- Geen gegevens
Nederlands
- English
- 简体中文
- 繁体中文
- Français
- Русский
- Italiano
- 日本語
- 한국어
- Português
- Deutsch
- Español
- Türkçe
- Ελληνικά
- Nederlands
- Tiếng Việt
- Polski
Recently, French silicon photonics company Scintil Photonics announced an exciting collaboration, successfully integrating III-V-DFB lasers and amplifiers with standard silicon photonics technology in the production of Israeli semiconductor company Tower Semiconductor. This milestone collaboration marks a crucial step for Scintil in strengthening its supply chain, bringing new possibilities to com...
Recently, American laser cleaning system developer Laser Photonics announced that the company has successfully secured an order for a cleaning technology laser cleaning system from Lufthansa Technik Puerto Rico, a technology subsidiary of Lufthansa, the largest aviation group in Europe.Lufthansa Technik is the world's largest independent provider dedicated to providing maintenance, repair, and com...
Researchers from Columbia University in New York reported the latest research on reverse laser sintering of metal powders. The related achievements were published in Scientific Reports under the title "Invested laser sintering of metal powder".The researchers demonstrated the ability of reverse laser sintering technology to manufacture metal powder parts. Researchers first deposit a layer of coppe...
Researchers from the Pacific Northwest National Laboratory and Johns Hopkins University have reported that machine learning and molecular dynamics simulations can help to gain a deeper understanding of the formation of condensation rings in laser spot welding. The related paper titled 'Machine learning and molecular dynamics simulations aided insights into conditioned ring formation in laser spot ...
On July 3rd local time, Swiss ophthalmic care giant Alcon announced the acquisition of Israeli medical technology company Belkin Vision and its laser equipment assets for treating glaucoma.The transaction includes a prepayment of $81 million, of which approximately $65 million is in cash. In addition, if Alcon can establish this technology as the preferred first-line treatment option for clinical ...